Lehigh Valley Health Network

LVHN Scholarly Works
Department of Medicine

Obscure Gastrointestinal Bleeding: A Case Series
Eric Nellis MD
Lehigh Valley Health Network, eric.nellis@lvhn.org

Patrick Hickey DO
Lehigh Valley Health Network, Patrick.Hickey@lvhn.org

Shashin Shah MD
Lehigh Valley Health Network, Shashin.Shah@lvhn.org

Hiral N. Shah MD
Lehigh Valley Health Network, hiral_n.shah@lvhn.org

Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine
Part of the Gastroenterology Commons, and the Medical Sciences Commons
Published In/Presented At
Nellis, E. Hickey, P. Shah, S. Shah, H. (Sept,2016). Obscure Gastrointestinal Bleeding: A Case Series. Poster Presented at: Pennsylvania
Society of Gastroenterology, Pocono Manor, PA.

This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.

Obscure Gastrointestinal Bleeding: A Case Series
Eric Nellis, MD, Patrick Hickey, DO, Shashin Shah, MD and Hiral Shah, MD
Lehigh Valley Health Network, Allentown, Pennsylvania

Case 2

Discussion

A 60-year-old male with a prior history of localized tonsillar SCC
treated with chemoradiation was deemed to have NED three years
ago. He presented with six weeks of fatigue and melena. Initial
laboratory evaluation confirmed iron deficiency anemia. A
screening colonoscopy one month prior was normal. Inpatient
EGD was unremarkable. VCE revealed bleeding in the jejunum. PE
showed blood refluxing into the most distal reachable site. DBE
revealed a circumferential luminal mass with denuded, ulcerated
mucosa. Biopsy showed moderately differentiated SCC. Abdominal
CT showed diffuse adenopathy with a focal area of small bowel
thickening. Further evaluation and treatment are pending.

Adenocarcinoma is the second most common malignant tumor of the small
bowel after carcinoid tumor. It usually located in the duodenal region with an
average age of diagnosis of 67. Seven percent of cases present with overt
gastrointestinal bleeding. Primary small bowel malignancy is rare, accounting
for 3% of gastrointestinal tract neoplasms and 0.5% of all cancers in the United
States. Metastatic lesions to the small bowel are even more rare. They can be
seen in the setting of peritoneal carcinomatosis with local extension. Melanoma,
sarcoma, lung, breast, cervical and colonic tumors are more likely to spread
to the small bowel hematogenously. Distant metastases from head and neck
cancers can be found in 7.4% of patients using PET/CT, and most commonly
involve the lungs, liver and bone. Gastroenterologists need to be considerate of
small bowel neoplasms in patients with OGIB.

Case 1

Background

Obscure gastrointestinal bleed (OGIB)
is defined as occult or overt bleeding
of unknown origin that persists after
initial negative endoscopic evaluation.
After considering repeat endoscopies
other assessment options include
push enteroscopy (PE), video capsule
endoscopy (VCE) and double-balloon
enteroscopy (DBE). We describe two
patients who presented with OGIB
related to malignancy.

A 43-year-old male presented with worsening fatigue and was
found to have profound anemia requiring blood transfusion. No
source of GIB was found on routine upper endoscopy and
colonoscopy. VCE findings suggested a relatively proximal
bleeding duodenal mass. A PE showed a duodenal AVM as well as
a hemi-circumferential ulcerated mass in the third portion of the
duodenum. Pathology was consistent with adenocarcinoma. Follow
up abdominal and thoracic CT showed multifocal adenopathy with
a mass in the distal duodenum. LN biopsy confirmed metastatic
duodenal adenocarcinoma. Given his disease stage he was not felt
to be a surgical candidate. He was started on FOLFOX therapy in an
attempt to downstage his disease.
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Figure 1. Hemi-circumferential ulcerated mass found to be
adenocarcinoma of the small bowel on biopsy.

Figure 2. Circumferential jejunal mass found to be metastatic
squamous cell carcinoma on biopsy.

Table 1. Common Causes of Obscure Gastrointestinal Bleeding
Over Age 50

Under Age 50

(Angioectasias (30-40%)

Tumors (carcinoid, leiomyoma, lymphoma,
adenocarcinoma)
NSAID Enteropathy
Inflammatory Bowel Disease
Meckel’s Diverticulum
Dieulafoy’s Lesions
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